Filing Details
- Accession Number:
- 0001645842-22-000102
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-07 16:54:24
- Reporting Period:
- 2022-07-05
- Accepted Time:
- 2022-07-07 16:54:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1645842 | Zymergen Inc. | ZY | Services-Commercial Physical & Biological Research (8731) | 462942439 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1668163 | Mina Kim | 5980 Horton Street, Suite 105 Emeryville CA 94608 | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-07-05 | 2,924 | $1.32 | 304,931 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The shares were sold to cover the tax obligation that occurred upon the vesting of RSUs.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices no more than $1.36 and no less than $1.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.